Zhejiang Sunflower Light Energy (300111) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Sunflower Light Energy (300111) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.42 Million ≈ $354.23K USD) by net assets (CN¥826.15 Million ≈ $120.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Sunflower Light Energy (300111) defensive interval to measure how many days the company can operate on defensive assets alone.
Zhejiang Sunflower Light Energy - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Zhejiang Sunflower Light Energy's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zhejiang Sunflower Light Energy Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Sunflower Light Energy ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Turvo International Co Ltd
TW:2233
|
0.038x |
|
Bar Harbor Bankshares Inc
NYSE MKT:BHB
|
0.009x |
|
Ningbo Homelink Eco-iTech Co. Ltd.
SHE:301193
|
-0.049x |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
-0.003x |
|
Sparebank 1 Ostfold Akershus
OL:SOAG
|
0.060x |
|
Zhejiang Dafeng Industrial Co Ltd
SHG:603081
|
0.052x |
|
Prime Medicine, Inc. Common Stock
NASDAQ:PRME
|
-0.557x |
|
Jensen-Group NV
BR:JEN
|
0.102x |
Annual Cash Flow Conversion Efficiency for Zhejiang Sunflower Light Energy (2007–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Sunflower Light Energy from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Sunflower Light Energy (300111) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥819.16 Million ≈ $119.87 Million |
CN¥4.20 Million ≈ $614.20K |
0.005x | -86.59% |
| 2024-12-31 | CN¥822.98 Million ≈ $120.43 Million |
CN¥31.44 Million ≈ $4.60 Million |
0.038x | +977.53% |
| 2023-12-31 | CN¥809.53 Million ≈ $118.46 Million |
CN¥2.87 Million ≈ $419.94K |
0.004x | -93.91% |
| 2022-12-31 | CN¥414.84 Million ≈ $60.70 Million |
CN¥24.16 Million ≈ $3.54 Million |
0.058x | -75.93% |
| 2021-12-31 | CN¥410.25 Million ≈ $60.03 Million |
CN¥99.27 Million ≈ $14.53 Million |
0.242x | +23.02% |
| 2020-12-31 | CN¥271.06 Million ≈ $39.66 Million |
CN¥53.31 Million ≈ $7.80 Million |
0.197x | -42.26% |
| 2019-12-31 | CN¥171.75 Million ≈ $25.13 Million |
CN¥58.50 Million ≈ $8.56 Million |
0.341x | -6.55% |
| 2018-12-31 | CN¥177.16 Million ≈ $25.92 Million |
CN¥64.58 Million ≈ $9.45 Million |
0.365x | +132.94% |
| 2017-12-31 | CN¥1.31 Billion ≈ $192.13 Million |
CN¥205.46 Million ≈ $30.07 Million |
0.156x | -44.26% |
| 2016-12-31 | CN¥1.30 Billion ≈ $190.34 Million |
CN¥365.14 Million ≈ $53.43 Million |
0.281x | +57.08% |
| 2015-12-31 | CN¥1.27 Billion ≈ $185.22 Million |
CN¥226.22 Million ≈ $33.10 Million |
0.179x | +90.07% |
| 2014-12-31 | CN¥1.21 Billion ≈ $176.79 Million |
CN¥113.60 Million ≈ $16.62 Million |
0.094x | +56.31% |
| 2013-12-31 | CN¥1.16 Billion ≈ $169.84 Million |
CN¥69.82 Million ≈ $10.22 Million |
0.060x | -83.24% |
| 2012-12-31 | CN¥1.13 Billion ≈ $164.96 Million |
CN¥404.72 Million ≈ $59.22 Million |
0.359x | +362.17% |
| 2011-12-31 | CN¥1.49 Billion ≈ $217.98 Million |
CN¥115.72 Million ≈ $16.93 Million |
0.078x | -45.63% |
| 2010-12-31 | CN¥1.66 Billion ≈ $242.74 Million |
CN¥237.02 Million ≈ $34.68 Million |
0.143x | +6.92% |
| 2009-12-31 | CN¥616.58 Million ≈ $90.23 Million |
CN¥82.39 Million ≈ $12.06 Million |
0.134x | +141.52% |
| 2008-12-31 | CN¥409.97 Million ≈ $59.99 Million |
CN¥-131.96 Million ≈ $-19.31 Million |
-0.322x | +73.14% |
| 2007-12-31 | CN¥103.31 Million ≈ $15.12 Million |
CN¥-123.82 Million ≈ $-18.12 Million |
-1.199x | -- |
About Zhejiang Sunflower Light Energy
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pne… Read more